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   Background 
The clinical definition of Cardiogenic shock is decreased 
cardiac output and evidence of tissue hypoxia in the presence 
of adequate intravascular volume.  
https://emedicine.medscape.com/article/152191-overview 
 
 
Left bundle branch block (LBBB) is an independent negative 
prognostic marker in acute myocardial infarction. A diagnosis of 
MI with ECG is especially difficult in the setting of LBBB 
because of the characteristic ECG changes caused by altered 
ventricular depolarization. 
(Bryan Wilner, etc, 2017 Americal College of Cardiology) 
 
 Epidemiology 
 Epidemiologically proven, 5%-15% of patients with Acute Myocardial Infarction 
(AMI) develop cardiogenic shock (CS) 
D. Kalavrouziotis et all  Canadian Journal of Cardiology 33 (2017) 36e43 
 
 
 Even with the introduction of modern intensive care units (ICUs), advanced medical 
treatment, and invasive devices, in-hospital death rates remain high at 40%-50%, 
despite advances in early revascularization and adjunctive pharmacotherapy                                                                                                                             
Eur Heart J 2015;36:1223-30 
 
 In large study with 72,765 cardiogenic shock patients (J.B.Echouffo-Tcheugui, 2018) 
were found that pre-existing diabetes (DM) was associated with an increased risk of 
cardiogenic shock (5.8% vs 5.2%; adjusted odds ratio [aOR] 1.14) and it worsens 
outcomes (higher in-hospital mortality (37.9% vs 36.8%; aOR 1.18), with a longer 
hospital stay (mean ± SEM: 11.6 ± 0.16 vs 10.9 ± 0.16 days)).                                                                                                                             
https://doi.org/10.1016/j.amjmed.2018.03.004 
 
Clinical case 
 Patient   - S.A.P 
 Age  - 72 
 Gender  -  Female 
 Occupation - House Wife 
 Date of hospital administration -  12-December-2017 
 
Complaints on admission 
 12-dec-2017 - Patient was  delivered by ambulance with 
complaints of general weakness and dyspnea on minimal 
physical exertion. 
 
  Intensive chest pain bothered patient on 11-dec-2017 at 
9pm for which the patient has consecutively taken 6 tablets 
of Nitroglycerin. 
 
  On admission moment patient denies chest pain as 
complain. 
Past Medical History 
 1995 – Diabetes mellitus type II, constantly receiving treatment with “Lantus” 40 
IU/day and Glybenclimide 5 mg/day 
 1999 – History of Arterial hypertension controlled by: 
Sartan 
Ca2+ - channel blocker 
Bisoprolol  
    [ Max BP 220/110, min 140/70 mmHg]  
 2010 – Initial appearance of retrosternal chest pain.  
 Received routine double - therapy with Aspirin + Ticagrelor  
 No MI or stroke in anamnesis 
Cont. 
 2011- Coronarography revealed diffuse atherosclerosis of coronary 
arteries for which PCI with stenting was performed 
 Post PCI - No chest pain or physical exertion intolerance 
 Subsequently, symptoms reappeared elementarily in 2016  
 RCA - Critical occlusion before bifurcation with stenting (arrow), TIMI -
1 before stenting, in proximal segment – stenosis 70%, in middle 
segment – 50% 
 LCA - prolonged atherosclerotic plaque with sub-occlusion in left 
anterior descending branch (stenting-arrow), atherosclerosis of 
diagonal branches, diffuse stenosis of circumference branch – 60-
70% 
 Before stenting diagnosis of stable angina  IV class according to 
NYHA 
 After stenting blood circulation – TIMI3 
 
LCA 
RCA 
  Electrocardiogram - 2014 
 Sinus rhythm, 
HR 80 in min. 
Normal heart 
axis. Relative 
signs of LV 
hypertrophy.  
    
 Repolarization 
alternation in 
anterior-lateral 
LV wall. 
Objective examination on admission 
 Conciseness – Lethargic. State –Severe, Body position - Passive 
 Skin and Mucosae – pale, acrocyanosis, cyanosis of lips 
 BMI – 32 kg/m2  
 RR – 18 /min, SpO2 – 75% 
 Pulse – Rhythmic, 90 bpm 
 BP- 110 / 60 mm/Hg  
 Pulmonary:  
 Percussion- Insignificant.  
 Auscultation:  
a) Decreased breath sounds over inferior and lateral parts of lungs 
b) Wheezing over both lung feilds 
c) Rales below both scapular angles. 
Cont. 
 Cardiovascular:  
 Percussion:  Left border displaced 1.5 cm away from midclavicular line. 
 Auscultation: Rhythmic, Heart sounds – Muffled  
 Abdomen: Normal size, symmetric, no tenderness  
 Liver: Enlarged, +2cm  with no tenderness 
 Spleen: Normal  
 Edemas: Pitting edemas 
 CVAT - Negative 
Conclusion 
 Sinus rhythm,  HR – 83 
bpm.  
 Left axis deviation. LBBB 
(QRS - 0,12s). 
 Paired supraventricular 
extrasystoles (in V1). 
 Posterior myocardial 
infarction (ST-segment 
elevation greater than or 
equal to 0.1 mV (1 mm) 
in leads with a positive 
QRS complex, and ST 
depression greater than 
or equal to 0.1 mV (1 
mm) in leads V1 through 
V3, ie, leads with a 
dominant S wave. 
Negative  Т in 1 and aVL, 
Q wave start of 
formation). 
2:01 am 
 Clinically: 
• Dyspnea, exacerbated by horizontal position and in minimal exertion. 
• Conciseness, sleepy??, State –severe. Acrocyanosis, cyanosis of lips.  
• RR – 26 bpm. SpO2 – 82%. 
• Crackles in lower lung fields. Heart sounds are muffled, rhythmic. HR- 68 bpm.  
• BP- 90/60 mm/Hg on dopamine infusion. Diuresis by catheter 8-10:00 is 10 ml 
     Conclusion: 
• Sinus rhythm,  HR-84 bpm. 
• Left axis deviation. LBBB (QRS 
- 0,12s).  
• Positive Q wave, posterior 
myocardial infarction (ST-
segment elevation greater than 
or equal to 0.1 mV (1 mm) in 
leads with a positive QRS 
complex in III and aVF, and ST 
depression greater than or equal 
to 0.1 mV (1 mm) in leads V1 
through V3, ie, leads with a 
dominant S wave. Reciprocal 
negative  Т in 1 and aVL, 
Q=0.02 sec, 4mm), negative 
dynamics comparing with 
previous. 
3:30 pm 
 Clinically: 
• BR – 30 in min. SO2 – 63%. 
• HR=Ps=66 in min 
•  BP 85/60 mm Hg on 
dopamine infusion 
background. Pitting edemas. 
• Diuresis by catheter 8-14:00 
is 20 ml.  
• On behalf of pulmonary 
edema treatment was added 
Sol. Morphini hydrochloride 
1% - 1ml in 10 ml 0,9% NaCl 
solution bolus, Furosemide 
60mg intravenously, venous 
tourniquets placement, O2 
inhalation. 
 Therapy with CVR, artificial lung ventilation in CMV regimen, adrenalin 0,18%-1ml and atropine 0,9%-10ml  
 18:55 (6:55 pm) unconsciousness, wide pupils, no photoreactions. 
Respiration is absent, no BP or pulse on main vessels. ECG: isoline. 
Biological death. 
 18:42  (6:42pm) unconsciousness, wide pupils, no respiration, no BP or pulse 
on main vessels. ECG: idioventricular rhythm 
Complete blood count 
Pts ranges Normal Range 
Hemoglobin, g/l 100 120-140 
Red blood cells, 1012 3,5 3,9-4,7 
Color index 0,75 0,85-1,15 
White blood cells, 109 14,7 4-9 
ESR, mm/h 3 2-15 
Bands 3 1-6% 
Segments 56 47-72% 
Eosinophils 3 0,5-5% 
Monocytes 2 3-11% 
Lymphocytes 36 19-37% 
Platelets 185 180-320 
Conclusion: Mild hypochromic anemia and leukocytosis 
Biochemical panel 
Glucose profile (3,3-5,5) 
1:30 26,6 mmol/l 
8:30 15,0 mmol/l 
11:00 13,2 mmol/l 
13:00 10,2 mmol/l 
Troponin I (till 0,5) 
1:30 0,84 ng/ml 
Conclusion: Poorly controlled Hyperglycemia and Troponin I elevation 
Echocardiography on admission 
Left Ventricle: 
• FDD – 59 mm (N – 35 – 55mm         -FSD – 48 
mm (N – 23 – 38 mm) 
• FDV – moderately increased – 174 ml 
• EF – 35% (N - 55 – 78%).  
• Stroke volume – 62 ml - increased 
• Posterior wall thickness in diastole– 13 mm (N 
– 6 – 13mm). Mild hypertrophy of LV wall 
• Intraventricular wall thickness in diastole – 12 
mm 
• Mitral regurgitation II stage 
 
Right Ventricle: 
• Diameter – 25 mm (N – 9 – 26 mm) 
Wall thickness – 0,4 mm (N – 0,5 mm)changed. 
 
Left atrium: 
•  Dilated - 45 mm in diameter ( N – till 39 mm) 
Right atrium:  
• Dilated – 37 mm in diameter (N – 25-37).  
Conclusion: Dilation of left heart chambers, LV hypertrophy.  Diffuse contractility decline 
Chest  X-ray 
Decreased lung transparency. 
  Lung roots – intensive, not 
structured. 
Diaphragmal and costal sinuses 
are dark, not visualized.  
Heart – increased in diameter, 
with non precise contours. Aorta 
- unchanged.  
Conclusion: Congestive 
changes, probable pulmonary 
edema 
Final Diagnosis 
 Main:  
 CAD: Acute (10.dec.2017) posterior MI type I, atherosclerotic cardiosclerosis, 
aorta and coronary arteries atherosclerosis.  
 Stenosing coronary sclerosis (PCI 2011).  
 Arterial hypertension III stage, very high risk 
 Complications: 
 Acute heart failure IV stage by Killip. Pulmonary edema, recurrent.  
 Cardiogenic shock (12 dec 2017) III stage. 
 Bilateral pleural effusion 
 Complete left bundle branch block 
 Asystole (12.12.2017 18:55) 
 Concomitant diseases:  
 Diabetes mellitus 2 type, insulin dependent, severe. Anemia of chronic disease, 
mild. 
Mortality factors of Cardiogenic Shock 
• Right bundle branch block  
• Left bundle branch block (LBBB) is an independent negative prognostic marker 
in acute Myocardial infarction (AMI) (30% vs.19%, p = 0.012, OR 1.57) .  
• Advanced age (75 years and more)  
• Large myocardial involvement, 
• Severe left ventricular dysfunction 
• Severity of end-organ injury 
• The glucose level at admission is a strong independent predictor for mortality 
• Comorbidities: STEMI, Dyslipidemia, Stroke, Diabetes mellitus 
 
Conclusion
 Probable causes of AMI after PCI performance in DM patients are: re-stenosis after PCI, progression of 
a separate untreated plaques, or the development of new ones with acceleration of negative remodeling 
owing to neointimal proliferation after PCI and increased platelet aggregation, small distal vessels 
microangiopathy and reduced collateral blood flow. 
 The current management of patients with acute myocardial infarction complicated by cardiogenic shock 
(AMI-CS) is associated with a high rate of mortality, despite widespread regional implementation of rapid 
transfer to percutaneous coronary intervention-capable centers for prompt infarct-related artery 
reperfusion. 
 In selected patients as our patient who was hemodynamically unstable,  
there might be a benefit associated with early institution of mechanical  
circulatory support before revascularization 
 Unloading the left ventricle during AMI to decrease LV wall stress, stroke  
work, and myocardial oxygen demand might limit myocardial cellular loss  
and decrease the extent of infarction. The major clinical utility of short-term  
mechanical circulatory support (MCS) is the reversal of shock by the  
restoration of cardiac output for distal organ and coronary perfusion. 
 
   Any questions?
